A 12-WEEK STUDY EVALUATING THE EFFECTS OF NIACIN ON VASCULAR HEALTH ASSESSED BY Fluorodeoxyglucose-PET/CT AND CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND MICROPARTICLES
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Niacin (Primary)
- Indications Arteriosclerosis
- Focus Pharmacodynamics
- Acronyms AVANT
- 18 Dec 2013 New trial record